Effects of Folfirinox and Stereotactic Body Radiation Therapy for Advanced Pancreatic Cancer

Effects of Folfirinox and Stereotactic Body Radiation Therapy for Advanced Pancreatic Cancer

Conditions: Pancreatic Cancer Non-resectable
Interventions: Drug: Folfirinox; Radiation: Stereotactic Body Radiation Therapy
Sponsors: University of Louisville; James Graham Brown Cancer Center
Completed

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

March 6, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments